Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2012-05-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm300335nPMID 22536944PMCID PMC3350798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Repairs DNA Damage Induced by Topoisomerases I and II and Base Alkylation in Vertebrate Cells*

  2012cited by this paper
• Interfacial inhibitors: targeting macromolecular complexes

  2012cited by this paper
• Effects of DNA and protein size on substrate cleavage by human tyrosyl-DNA phosphodiesterase 1.

  2011cited by this paper
• Interfacial inhibitors: targeting macromolecular complexes

  2011cited by this paper
• Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties.

  2010cited by this paper
• 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.

  2009cited by this paper
• DNA Topoisomerases

  2009cited by this paper
• Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay

  2009cited by this paper
• Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.

  2008cited by this paper
• DNA cleavage assay for the identification of topoisomerase I inhibitors

  2008cited by this paper
• Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1

  2007cited by this paper
• Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance.

  2007cited by this paper
• Investigation of the lactam side chain length necessary for optimal indenoisoquinoline topoisomerase I inhibition and cytotoxicity in human cancer cell cultures.

  2007cited by this paper
• Optimization of the indenone ring of indenoisoquinoline topoisomerase I inhibitors.

  2007cited by this paper
• Synthesis of benz[d]indeno[1,2-b]pyran-5,11-diones: versatile intermediates for the design and synthesis of topoisomerase I inhibitors.

  2006cited by this paper
• Topoisomerase I inhibitors: camptothecins and beyond

  2006cited by this paper
• Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes.

  2006cited by this paper
• Synthesis of Benz[d]indeno[1,2‐b]pyran‐5,11‐diones: Versatile Intermediates for the Design and Synthesis of Topoisomerase I Inhibitors.

  2006cited by this paper
• Synthesis and biological evaluation of bisindenoisoquinolines as topoisomerase I inhibitors.

  2006cited by this paper
• Inhibition of Human Tyrosyl-DNA Phosphodiesterase by Aminoglycoside Antibiotics and Ribosome Inhibitors

  2006cited by this paper
• Deficiency in 3′-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1)

  2005cited by this paper
• Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1

  2005cited by this paper
• SCAN1 mutant Tdp1 accumulates the enzyme–DNA intermediate and causes camptothecin hypersensitivity

  2005cited by this paper
• Substrate Specificity of Tyrosyl-DNA Phosphodiesterase I (Tdp1)*

  2005cited by this paper
• TDP1 Overexpression in Human Cells Counteracts DNA Damage Mediated by Topoisomerases I and II*

  2004cited by this paper
• Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase

  2004influential reference
• Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes.

  2004cited by this paper
• Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide.

  2003cited by this paper
• Repair of and checkpoint response to topoisomerase I-mediated DNA damage.

  2003cited by this paper
• Mutation of TDP1, encoding a topoisomerase I–dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy

  2002cited by this paper
• Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase.

  2002cited by this paper
• The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1.

  2002cited by this paper
• Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures.

  2002cited by this paper
• DNA topoisomerases: structure, function, and mechanism.

  2001cited by this paper
• Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae

  2001cited by this paper
• The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily

  2001cited by this paper
• Topoisomerase I-mediated DNA damage.

  2001cited by this paper
• Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.

  2000cited by this paper
• Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.

  1999cited by this paper
• Topoisomerase I inhibitors: selectivity and cellular resistance.

  1999cited by this paper
• Induction of Reversible Complexes between Eukaryotic DNA Topoisomerase I and DNA-containing Oxidative Base Damages

  1999cited by this paper
• Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.

  1998cited by this paper
• Trapping of Mammalian Topoisomerase I and Recombinations Induced by Damaged DNA Containing Nicks or Gaps

  1997cited by this paper
• Effects of Uracil Incorporation, DNA Mismatches, and Abasic Sites on Cleavage and Religation Activities of Mammalian Topoisomerase I*

  1997cited by this paper
• DNA topoisomerases.

  1996cited by this paper
• A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases.

  1996cited by this paper
• Eukaryotic DNA topoisomerases I.

  1995cited by this paper
• DNA topoisomerases: essential enzymes and lethal targets.

  1994cited by this paper

• TDP1 represents a promising therapeutic target for overcoming tumor resistance to chemotherapeutic agents: progress and potential.

  2024cites this paper
• Synthesis and Biological Activities of 11‐ and 12‐Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB and Tyrosyl‐DNA Phosphodiesterase 1 Inhibitors

  2023cites this paper
• Palladium-Catalyzed Synthesis of Indanone via C-H Annulation Reaction of Aldehydes with Norbornenes.

  2023cites this paper
• Topoisomerase I inhibitors: Challenges, progress and the road ahead.

  2022cites this paper
• Unexpected Formation of 4-[(1-Carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic Acid from 4-[(3-Amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic Acid

  2022cites this paper
• In Vitro and In Silico Studies of Human Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) Inhibition by Stereoisomeric Forms of Lipophilic Nucleosides: The Role of Carbohydrate Stereochemistry in Ligand-Enzyme Interactions

  2022cites this paper
• Synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their anticancer activity.

  2022cites this paper
• Design and Synthesis of Indenoisoquinolines Targeting Topoisomerase I and Other Biological Macromolecules for Cancer Chemotherapy.

  2021cites this paper
• Copper/silver co-mediated three-component bicyclization for accessing indeno[1,2-c]azepine-3,6-diones.

  2021cites this paper
• A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors

  2021cites this paper
• Synthesis, Antibacterial Activity and Photophysical Properties of Bis-benzamide derivatives

  2021cites this paper
• Cyclic Oxime Esters as Deconstructive Bifunctional Reagents for Cyanoalkyl Esterification of 1,6-Enynes.

  2021cites this paper
• The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo

  2021cites this paper
• An efficient one-pot synthesis of indanone fused heterocyclic compounds via SeO2/FeCl3 promoted intramolecular Friedel-Craft acylation reaction

  2021cites this paper
• Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions.

  2021cites this paper
• Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer.

  2021cites this paper
• Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors.

  2020cites this paper
• Palladium(II)‐Catalyzed Direct Access to Indeno[1,2‐ c ]isochromen‐5(11 H )‐Ones via Intramolecular Oxypalladation‐Initiated Cascade Process

  2020cites this paper
• Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.

  2020cites this paper
• Molecular docking, DFT and antimicrobial studies of Cu(II) complex as topoisomerase I inhibitor

  2020cites this paper
• Metal‐Free Radical Annulation‐Hydrofunctionalization of 1,6‐Enynes for Stereoselective Synthesis of ( E )‐1‐Indanones

  2020cites this paper
• Gold-Catalyzed Cyclisation by 1,4-Dioxidation.

  2019cites this paper
• Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activit

  2019cites this paper
• The Development of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. Combination of Monoterpene and Adamantine Moieties via Amide or Thioamide Bridges

  2019cites this paper
• The Development of Tyrosyl-DNA Phosphodyesterase 1 (TDP1) Inhibitors Based on the Amines Combining Aromatic/Heteroaromatic and Monoterpenoid Moieties

  2019cites this paper
• Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening.

  2019cites this paper
• Dual DNA topoisomerase 1 and tyrosyl‐DNA phosphodiesterase 1 inhibition for improved anticancer activity

  2019influential citation
• Design and synthesis of a DNA intercalative half-sandwich organoruthenium(ii)–chromone complex: cytotoxicity evaluation and topoisomerase Iα inhibition assay

  2019cites this paper
• Crystal structure of Tdp1 catalytic domain in complex with compound XZ578

  2019cites this paper
• Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models.

  2019cites this paper
• Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments.

  2019cites this paper
• Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.

  2018cites this paper
• Synthesis, anti‐cancer screening and tyrosyl‐DNA phosphodiesterase 1 (Tdp1) inhibition activity of novel piperidinyl sulfamides

  2018cites this paper
• Synthesis and Inhibitory Properties of Imines Containing Monoterpenoid and Adamantane Fragments Against DNA Repair Enzyme Tyrosyl-DNA Phosphodiesterase 1 (Tdp1)

  2018cites this paper
• A polysaccharide from Antrodia cinnamomea mycelia exerts antitumor activity through blocking of TOP1/TDP1-mediated DNA repair pathway.

  2018cites this paper
• Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.

  2018cites this paper
• Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2).

  2018cites this paper
• Alpha-terpineol affects synthesis and antitumor activity of triterpenoids from Antrodia cinnamomea mycelia in solid-state culture.

  2018cites this paper
• Single X-ray crystal structure, DFT studies and topoisomerase I inhibition activity of a tailored ionic Ag(I) nalidixic acid–piperazinium drug entity specific for pancreatic cancer cells

  2018cites this paper
• Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors

  2018cites this paper
• DNA Repair Enzymes as Promising Targets in Oncotherapy

  2018cites this paper
• USING OF 3-ARYLISOCOUMARINS IN 3-ARYLISOQUINOLONS SYNTHESIS

  2017cites this paper
• DNA-Damaging Anticancer Drugs - A Perspective for DNA Repair- Oriented Therapy.

  2017cites this paper
• Tyrosyl–DNA phosphodiesterases: rescuing the genome from the risks of relaxation

  2017cites this paper
• Virtual Screening for the Development of Dual-Inhibitors Targeting Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1.

  2017cites this paper
• Structure Modeling of Human Tyrosyl-DNA Phosphodiesterase 1 and Screening for Its Inhibitors

  2017cites this paper
• Retinoid X Receptor Selective Agonists and their Synthetic Methods.

  2017cites this paper
• Type I DNA Topoisomerases.

  2017cites this paper
• Usnic acid derivatives are effective inhibitors of tyrosyl-DNA phosphodiesterase 1

  2017cites this paper
• Processing Strand Break Termini in the DNA Single-Strand Break Repair Pathway

  2017cites this paper
• Silver-mediated radical 5-exo-dig cyclization of 2-alkynylbenzonitriles: synthesis of phosphinylated 1-indenones.

  2017cites this paper
• Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.

  2017cites this paper
• Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).

  2017cites this paper
• Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.

  2016cites this paper
• Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin.

  2016cites this paper
• New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties.

  2016cites this paper
• Synthesis and biological evaluation of 6-fluoro-3-phenyl-7-piperazinyl quinolone derivatives as potential topoisomerase I inhibitors.

  2016cites this paper
• Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.

  2016cites this paper
• Human Topoisomerase I Inhibitors

  2016cites this paper
• Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2).

  2016cites this paper
• Synthesis and cytotoxic evaluation of novel indenoisoquinoline-propan-2-ol hybrids

  2016cites this paper
• Synthesis of tyrosyl-DNA phosphodiesterase I inhibitors

  2016cites this paper
• Human Topoisomerase I mediated cytotoxicity profile of l-valine-quercetin diorganotin(IV) antitumor drug entities

  2016cites this paper
• Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.

  2016cites this paper
• The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl‐DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis

  2015cites this paper
• Indeno–furan based colorimetric and on–off fluorescent pH sensors

  2015cites this paper
• Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.

  2015cites this paper
• Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety.

  2015cites this paper
• Crystal structure determination, spectroscopic characterization and biological profile of a tailored ionic molecular entity, Sn(IV) iminodiacetic acid–piperazinediium conjugate: in vitro DNA/RNA binding studies, Topo I inhibition activity, cytotoxic and systemic toxicity studies

  2015cites this paper
• Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.

  2015cites this paper
• Tyrosyl-DNA phosphodiesterase 1 is a new player in repair of apurinic/apyrimidinic sites

  2015cites this paper
• Inhibitory properties of nitrogen-containing adamantane derivatives with monoterpenoid fragments against tyrosyl-DNA phosphodiesterase 1

  2015cites this paper
• Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).

  2014cites this paper
• Synthesis of Fused Cyclopentenones through Palladium‐Catalyzed Cyclization of 2‐Iodoaryl Allenols

  2014cites this paper
• Synthesis and Biological Evaluation of New Carbohydrate-Substituted Indenoisoquinoline Topoisomerase I Inhibitors and Improved Syntheses of the Experimental Anticancer Agents Indotecan (LMP400) and Indimitecan (LMP776)

  2014cites this paper
• Identification of a Putative Tdp1 Inhibitor (CD00509) by in Vitro and Cell-Based Assays

  2014cites this paper
• Design, Synthesis, and Biological Evaluation of O-2-Modified Indenoisoquinolines as Dual Topoisomerase I–Tyrosyl-DNA Phosphodiesterase I Inhibitors

  2014cites this paper
• Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform.

  2014cites this paper
• Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target

  2014cites this paper
• Design, synthesis, and biological evaluation of indenoisoquinoline rexinoids with chemopreventive potential.

  2013cites this paper
• Palladium(II)-catalyzed synthesis of functionalized indenones via oxidation and cyclization of 2-(2-arylethynylphenyl)acetonitriles.

  2013cites this paper
• Role of Tyrosyl-DNA Phosphodiesterase I (TDP1) as a Prognostic and Predictive Factor in Malignant Glioma

  2013cites this paper
• Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).

  2013cites this paper
• A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors.

  2013cites this paper
• Correction to Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)-Topoisomerase I (Top1) Inhibitors.

  2012cites this paper
• 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.

  2012cites this paper